Biontech Se Stock Investor Sentiment

BNTX Stock  USD 112.92  4.12  3.79%   
Slightly above 54% of BioNTech's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding BioNTech SE suggests that some traders are interested. BioNTech's investing sentiment can be driven by a variety of factors including economic data, BioNTech's earnings reports, geopolitical events, and overall market trends.

Comfort Level 54

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use BioNTech's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward BioNTech SE.
48.0%
64.0%
50.0%

BioNTech Historical Sentiment

Although BioNTech's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding BioNTech, such as negative comments on social media and news outlets, may cause fear in the market and push BioNTech's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of BioNTech.
  

BioNTech Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards BioNTech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
54.9%
56.5%
53.7%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

BioNTech SE Historical Investor Sentiment

Investor biases related to BioNTech's public news can be used to forecast risks associated with an investment in BioNTech. The trend in average sentiment can be used to explain how an investor holding BioNTech can time the market purely based on public headlines and social activities around BioNTech SE. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioNTech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioNTech and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average BioNTech news discussions. The higher the estimate score, the more favorable the investor's outlook on BioNTech.
over three months ago at benzinga.com         
This Bank of America Analyst Turns Bullish Here Are Top 5 Upgrades For Friday
benzinga news
over three months ago at cnbc.com         
Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25
cnbc News
over three months ago at investing.com         
BioNTech stock sees upgrade as Goldman Sachs eyes BNT327 opportunity
Investing News at Macroaxis
over three months ago at investing.com         
BioNTech shares upgraded on new cancer drug potential
Investing News at Macroaxis
over three months ago at thelincolnianonline.com         
BioNTech Issues Quarterly Earnings Results, Beats Expectations By 2.07 EPS
news
over three months ago at benzinga.com         
Trumps Potential Health Czar Robert F. Kennedy Jr. Rattles Vaccine Stocks Shoot First Reaction
benzinga news
over three months ago at simplywall.st         
BioNTech SE Just Reported A Surprise Profit And Analysts Updated Their Estimates
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
Results BioNTech SE Confounded Analyst Expectations With A Surprise Profit
Yahoo News
over three months ago at gurufocus.com         
BioNTech SE Q3 2024 Earnings Call Highlights Revenue Surge and Strategic Advancements ...
Gurufocus Stories at Macroaxis
over three months ago at insidermonkey.com         
BioNTech SE Q3 2024 Earnings Call Transcript
insidermonkey News
over three months ago at simplywall.st         
BioNTech Third Quarter 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over three months ago at finance.yahoo.com         
BioNTech Third Quarter 2024 Earnings Beats Expectations
Yahoo News
over three months ago at finance.yahoo.com         
BioNTech SE Q3 2024 Earnings Call Highlights Revenue Surge and Strategic Advancements ...
Yahoo News
over three months ago at finance.yahoo.com         
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
Yahoo News
over three months ago at globenewswire.com         
BioNTech verffentlicht Ergebnisse fr das dritte Quartal 2024 sowie Informationen zur Geschftsentwick...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about BioNTech that are available to investors today. That information is available publicly through BioNTech media outlets and privately through word of mouth or via BioNTech internal channels. However, regardless of the origin, that massive amount of BioNTech data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BioNTech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioNTech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioNTech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioNTech alpha.

BioNTech Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.1512345678910Dec2025Feb -5051015
JavaScript chart by amCharts 3.21.15BioNTech SE BioNTech SE Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Redmile Group LLC Invests 18.35 Million in BioNTech SE
12/05/2024
2
Bullish Outlook On Instil Bios Investigational Cancer Drug Jefferies Sees Over 300 percent Stock Upside
01/07/2025
3
3 Dirt-Cheap Stocks to Buy in a Market Thats Priced for Perfection
01/22/2025
4
Heres How to Play Pfizer Stock Before Q4 Earnings Release
01/28/2025
5
Vaccine stocks in the spotlight as RFK Jr. faces Senate questioning - report
01/29/2025
6
BioNTech schliet bernahme von Biotheus ab
02/03/2025
7
What Makes BioNTech a New Buy Stock
02/13/2025
8
BioNTech RD remains the focus -February 21, 2025 at 0434 am EST - Marketscreener.com
02/21/2025
9
BioNTech verffentlicht am 10. Mrz 2025 Ergebnisse fr das vierte Quartal und das Geschftsjahr 2024 und informiert ber operativen Fortschritt
02/24/2025
10
BioNTech SE to Announce Q4 and Full Year 2024 Financial Results
02/25/2025

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.